Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Mar 13, 2019 · 10-K · 72 days after period end · 0001171843-19-001687
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$5.26M | -$5.55M | -$6.96M | -$6.34M |
| EPS Diluted | -$0.27 | -$0.33 | -$0.42 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 13, 2019 · 72 d after period end
